Share your Rare: Alice's Story
Written by Alice, Alexík’s rare mom from the Czech Republic
A sudden medical emergency
Alexík was born a healthy child and had no health complaints until he was five and a half years old. He had a tick infection at the age of three, but, even after this, there were no signs of a serious illness. In November of 2018, the flu came, and, despite a timely treatment, the virus got where it shouldn't have. A brain inflammation occurred and, consequently, an epileptic seizure took place. As this seizure was a grand mal lasting more than an hour, Alexík had to be put into a medically induced sleep.
The next day, the medical staff wanted to wake him up, but another strong grand mal followed. Alexík was in a sleep–induced coma for more than a month, fighting. Then, the medics managed to put him in a light sleep; however, the risk of a tracheostomy was high because Alexík couldn't breathe. During his coma, he developed pneumonia, which happens with lung ventilation. As Alexík fought for breath, the seizures caused irreversible brain damage.
After waking up, Alexík had to re-learn everything, from swallowing to communicating. He was like a big baby. Afterward, different diagnoses started coming. At first, the doctors thought it was acute disseminated encephalomyelitis (ADEM); however, later on, this was re-evaluated. Alexík was fighting, getting better, and everything seemed to be on the right track. Nevertheless, his deterioration manifested in the summer of 2019.
Living with three rare diseases
The doctors spoke about a neurodegenerative disease. Alexík's state of health was like a rollercoaster: he was a bedridden patient who, at times, would show some signs of improvement. He would take three steps forward, and then suddenly two or four steps back. Doctors searched for the cause and found it.
Initially, through a muscle biopsy of his leg, Alexík was diagnosed with a deficiency of mitochondrial respiratory chain complex IV. In the autumn of 2021, he was also diagnosed with Snijders Blok-Campeau syndrome (caused by mutations in the CHD3 gene) and leukoencephalopathy (caused by mutation of OPA1 and DOA genes). These diagnoses were all in the mitochondria and not inherited.
“The whole family and I fight together with him for better days.”
Alexík struggles with three rare diseases, epilepsy, severe behavioral disorders, and other associated diagnoses; he does not walk, he does not speak well, and, at the age of 9, he has the psychomotor skills of a preschooler. However, he is a great fighter. The whole family and I fight together with him for better days. The forecasts are dire, but I ignore them.
The challenges of being a mother and caregiver
At home, I do everything by myself, helping Alexík with his learning, his rehabilitation, etc. Because of all his diagnoses, he needs to be supervised at all times: he doesn't cooperate well, has an irregular circadian cycle - sleeps irregularly, needs 24/7 care, doesn't eat on his own, and has just started drinking through a straw.
Any infection is a big risk for Alexík, so we try to protect him. Alexík is very dependent on me - his mother. Without my presence, he becomes unmanageable, depressed, aggressive, and anxious, and experiences seizures...It is not easy, but I believe that Alexík will manage it and one day he will achieve some independence.
Alexík is so far the only one in the Czech Republic with Snijder's Block Campeau syndrome; there are a few other patients (mostly adults) living with the mutation of DOA and OPA1; I could not find any information on the respiratory chain complex IV deficiency.
Connect with Alice!
Latest from Know Rare
From prenatal uncertainty and postpartum anxiety to therapy, grief, and hope, a mother shares her experience raising a child with a rare disease, navigating the healthcare system, finding community, and learning to embrace a different—but deeply meaningful—path as a parent.
A Danon disease study, led by researcher Dr. Barry Greenberg and published in the New England Journal of Medicine, wins an award! The study focuses on gene therapy as a potential treatment option for Danon disease. The study showed early signs that gene therapy may help the hearts of people with Danon disease.
A poster, presented at the European Hematology Association meeting in June, described a study that looked at tiredness (fatigue) in adults with immune thrombocytopenia (ITP). Researchers wanted to see if fatigue was related to bleeding or other health test results.
Lucky Shanmugan was recently featured in Porter Ranch Living, his local magazine, for Father’s Day: in his interview, Lucky talks about Osteogenesis Imperfecta, a rare genetic or heritable disorder of the connective tissue, and the incredible journey towards his official diagnosis.
Here are 9 things Chris Anselmo wishes someone had told him after his rare disease diagnosis.
A family’s hardships and resilience in finding answers and getting a diagnosis for their child, after numerous tests, brain biopsies, and hospitalizations. And the relief but also grief in finally putting a name to the rare disease that affects their child: BCL11B-related disorder.
The Danon Foundation boldly empowers people living with Danon disease, providing trusted information, resources and support to help navigate life, from diagnosis to treatment.
For many families, caregiving for a child with a rare or medically complex condition is a full-time job. The problem is, it’s a job with no training, no time off, and no clear job description. If you’re looking for the light at the end of the tunnel, you don’t have to search alone. Check out some of Paige’s favorite resources.
For most of celiacs, despite months on a strict GF diet, energy stays low and blood work reveals nutrient deficiencies. The lesson? A "gluten-free" label isn't a health guarantee—just a guarantee you'll pay more.
If you’ve been told you have seronegative NMOSD, there’s nearly 50/50 chance you have a different antibody causing your symptoms –MOG antibody.
Therapy Near Me is a nationwide mental health service based in Australia, providing easy access to psychologists, counsellors, behaviour support practitioners and social workers.
At the annual Kidney Week of the American Society of Nephrologists (ASN), the world’s largest kidney healthcare professional organization, new advances in research were highlighted. Over $35 million has been invested in research with the ASN, and there are many treatments in development for IgA Nephropathy (IgAN), with researchers actively investigating more than 20 different drugs.
When I was diagnosed with celiac disease, I thought avoiding bread and pasta would be enough. I quickly learned that living truly gluten-free is far more complex, and I'm sharing my experience to help newly diagnosed individuals understand what lies ahead.
Retinopathy is an eye problem that many people with Danon disease have. It can cause dark spots in the outer part of the eye, blurry or worse vision, and unusual test results on an eye exam. Sometimes these eye changes show up before heart problems, so an eye check can help find the disease early.
A heartfelt story about a mother who found purpose and strength among the tragedy of losing a child diagnosed with an ultra rare genetic disorder.
Kaya Girl Legacy, Inc. is a Florida-based nonprofit founded in memory of Kaya Humbert, a beautiful baby girl born with Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS), one of 46 known cases worldwide. The foundation is dedicated to empowering families with knowledge about their genetic health and advocating for early access to genetic testing and rare disease awareness.
A prose poem by Jim Kuhn, a rare warrior living with Sarcoidosis, a rare inflammatory disease.
Rare Mom Laura shares how her family’s prep for Halloween turned into a burst of familial love and creativity, as they all worked together in designing and building a costume for Alden, her medically complex son.
Instead of starting with a newly discovered drug compound, PCOR is a type of research that starts by turning to patients and caregivers and asking, What matters most to you? What questions do we want answered? What symptoms do we wish were better managed? What keeps us up at night?
Four years ago, Michael Grivas’ life suddenly changed when he learned that he had Brugada Syndrome, a genetic disorder in which the electrical activity of the heart is abnormal due to channelopathy. Learn more about his story.
Fatigue is a very common and often debilitating symptom of IgAN. It is linked to disease progression and reduced kidney function, but other factors like inflammation, anemia, and mental health also play a role. In a 2025 study, the majority of patients with IgAN reported fatigue, and patients with more severe proteinuria and lower kidney filtration rates (eGFR) experienced worse fatigue.
Why is it so hard to accept help? Humans often associate help with weakness and loss of independence and control. However, if we reframe our thoughts, accepting help can be viewed as a form of empowerment: showing vulnerability and trusting someone to help us requires great strength.
There is so much mental load with having a rare disease. Rare Human Lindsay shares there are things she does not care about anymore, as she manages rare disease symptoms, specialists, and clinical trials.
Rare Human Lindsay shares her "silver linings." It's not 'what doesn't kill you makes you stronger,' instead it's what doesn't kill you makes you braver. She shares that she has found deeper connections with others, improved her ability to ask for and accept help, and not been as afraid of the word "no."
Journalist and rare disease advocate Lindsay Guentzel breaks down why clinical trials are a lifeline for the rare disease community. With only 5% of known rare diseases having an FDA-approved therapy, trials often represent the only path toward treatment, progress, and hope.
Lindsay was diagnosed with dermatomyositis a couple of years ago. Since then, she has undergone more than 350 doctor appointments, 250+ hours of infusions, 10+ ER visits, while juggling insurance approvals, rides, and her pain and fatigue.
Rare Human Lindsay is in the midst of her first clinical trial for dermatomyositis, a rare inflammatory disease that primarily affects the skin and muscles. So far, she has learned so much about the process and is eager to share some of her insights with the rare disease community.